EDGAR Filing Documents for 0000950103-18-004337

Form 8-K - Current report:

SEC Accession No. 0000950103-18-004337

Filing Date

2018-04-03

Accepted

2018-04-03 08:52:48

Documents

Period of Report

2018-04-03

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	dp89174_8k.htm	8-K	28332
2	EXHIBIT 4.1	dp89174_ex0401.htm	EX-4.1	379152
3	EXHIBIT 4.2	dp89174_ex0402.htm	EX-4.2	618827
4	EXHIBIT 99.1	dp89174_ex9901.htm	EX-99.1	9702
5	EXHIBIT 99.2	dp89174_ex9902.htm	EX-99.2	10829
6	GRAPHIC	image_001.jpg	GRAPHIC	3602
	Complete submission text file	0000950103-18-004337.txt		1053439

Mailing Address 251 BALLARDVALE ST WILMINGTON MA 01887

Business Address 251 BALLARDVALE ST WILMINGTON MA 01887 781-222-6000

CHARLES RIVER LABORATORIES INTERNATIONAL INC (Filer) CIK: 0001100682 (see all company filings)

IRS No.: 061397316 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15943 | Film No.: 18731449
SIC: 8731 Services-Commercial Physical & Biological Research